Haddy F, Pamnani M, Clough D
Clin Exp Hypertens (1978). 1978;1(3):295-336. doi: 10.3109/10641967809068611.
Decreased arterial Na+-K+ pump and cardiac Na+, K-+ATPase activities have now been demonstrated in several types of experimental volume expanded hypertension. The changes are not secondary to elevated pressure since they also occur in veins and right ventricle where the pressure is not elevated. Decreased arterial Na+-K+ pump activity can be reproduced by acute volume expansion of the normal rat and plasma extracts from this rat suppress pump activity when applied to arteries from another rat. Suppression of Na+-K+ pump activity in arteries, veins and heart, with ouabain for example, leads to increased contractile activity. Thus the volume expansion, reduced pump activity, and hypertension appear to be causally related through an ouabain-like humoral agent. Certain other evidence suggests that the pump defect extends to the sympathetic nerve endings, thereby reducing the efficiency of neural compensatory mechanisms.
现已证实在几种类型的实验性容量扩张性高血压中,动脉钠钾泵和心脏钠钾ATP酶活性降低。这些变化并非压力升高的继发结果,因为它们也发生在压力未升高的静脉和右心室中。正常大鼠急性容量扩张可重现动脉钠钾泵活性降低,并且将此大鼠的血浆提取物应用于另一只大鼠的动脉时,可抑制泵活性。例如,用哇巴因抑制动脉、静脉和心脏中的钠钾泵活性会导致收缩活性增加。因此,容量扩张、泵活性降低和高血压似乎通过一种类似哇巴因的体液因子存在因果关系。某些其他证据表明,泵缺陷延伸至交感神经末梢,从而降低了神经代偿机制的效率。